History Says Johnson & Johnson Beats Medtronic. Here’s Why I’d Still Consider MDT for the Next Decade.
Johnson & Johnson‘s (NYSE:JNJ) stock has absolutely crushed Medtronic‘s (NYSE:MDT) over the last decade. The iconic healthcare giant has generated a nearly 200% total return over the last 10 years (11.6% annualized), compared with roughly 35% for the healthcare technology company (3.1% annualized).
However, while Johnson & Johnson’s stock was the clear winner over the past decade, I think Medtronic could be the better investment over the next 10 years. Here’s why.
Image source: Getty Images.
Source: www.fool.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.